Avishek Roy

Postdoctoral researcher II Neuroscientist II Father

Extremely low intensity magnetic field effectively improves cognitive impairment in intracerebroventricular streptozotocin animal model sparing septo‐hippocampal cholinergic pathway and CAMKII


Journal article


Avishek Roy, T. Nag, Y. Gupta, S. Jain
Alzheimer's & Dementia, 2021

Semantic Scholar DOI PubMed
Cite

Cite

APA   Click to copy
Roy, A., Nag, T., Gupta, Y., & Jain, S. (2021). Extremely low intensity magnetic field effectively improves cognitive impairment in intracerebroventricular streptozotocin animal model sparing septo‐hippocampal cholinergic pathway and CAMKII. Alzheimer's &Amp; Dementia.


Chicago/Turabian   Click to copy
Roy, Avishek, T. Nag, Y. Gupta, and S. Jain. “Extremely Low Intensity Magnetic Field Effectively Improves Cognitive Impairment in Intracerebroventricular Streptozotocin Animal Model Sparing Septo‐Hippocampal Cholinergic Pathway and CAMKII.” Alzheimer's & Dementia (2021).


MLA   Click to copy
Roy, Avishek, et al. “Extremely Low Intensity Magnetic Field Effectively Improves Cognitive Impairment in Intracerebroventricular Streptozotocin Animal Model Sparing Septo‐Hippocampal Cholinergic Pathway and CAMKII.” Alzheimer's &Amp; Dementia, 2021.


BibTeX   Click to copy

@article{avishek2021a,
  title = {Extremely low intensity magnetic field effectively improves cognitive impairment in intracerebroventricular streptozotocin animal model sparing septo‐hippocampal cholinergic pathway and CAMKII},
  year = {2021},
  journal = {Alzheimer's & Dementia},
  author = {Roy, Avishek and Nag, T. and Gupta, Y. and Jain, S.}
}

Abstract

We have investigated the role of extremely‐low‐frequency magnetic field (ELF‐MF, 17.96µT, 50Hz, 2hr/day for 60 days) exposure on i.c.v. streptozotocin (STZ, 3mg/kg bw, bilaterally, single bolus) induced rat model of AD in a customized chamber.


Share

Tools
Translate to